Natco Pharma arm launches first generic alternative to Revlimid in Canada Medical Dialogues Team2 Sep 2021 10:58 AM GMTNew Delhi: Natco Pharma (Canada), a subsidiary of Natco Pharma Limited, announced the launch of PrNat-Lenalidomide Capsules, the first generic...
Aurobindo Pharma arm gets USFDA okay for Cyclophosphamide Injection ruchika27 Aug 2021 7:49 AM GMTHyderabad: Aurobindo Pharma Limited today announced that the company's subsidiary Eugia Pharma Specialities Ltd. has received a 505(b)(2) NDA approval...
Beta blockers show promise in managing multiple myeloma: European Journal of Haematology Dr Satabdi Saha7 July 2021 3:30 AM GMTBeta blockers when used synergistically with an immunomodulatory drug, Pomalidomide, has been reported to improve survival rates in patients with...
FDA approves cellular gene therapy for refractory multiple myeloma Dr Satabdi Saha5 April 2021 5:23 AM GMTIn a recent development,FDA has given a nod to the first gene therapy for patients of relapsed or refractory multiple myeloma who have received at...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 11:45 AM GMTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they hav...
Off-the-Shelf Immune Drug Shows Promise in Aggressive Multiple Myeloma Hina Zahid31 Dec 2020 12:00 PM GMTPHILADELPHIA - A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients...
Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US ruchika12 Dec 2020 11:06 AM GMTAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
Rare case of Cardiorenal Amyloidosis reported in JAPI Hina Zahid10 Aug 2020 5:45 PM GMTDr R Anand Senior Consultant, Radiology, Max Superspeciality Hospital, Saket, New Delhi has reported a case of Cardiorenal Amyloidosis which has been...
Bristol Myers Squibb gets EMA validation for Idecabtagene Vicleucel, CC-486 ruchika25 May 2020 10:23 AM GMTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Applications (MAA) for...
FDA approves new Daratumumab formulation for Multiple Myeloma patients Hina Zahid4 May 2020 12:02 PM GMTHORSHAM, Pa. - The U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPROâ„¢ (daratumumab and hyaluronidase-fihj), a new...
Treating COVID-19 in a patient with multiple myeloma: Case study Dr. Kamal Kant Kohli3 April 2020 4:18 PM GMTA case study published in Blood Advances has found that Aocilizumab was effective in addressing COVID-19 symptoms for people with blood cancers
FDA approves new therapy for progressive multiple myeloma Dr. Kamal Kant Kohli3 March 2020 4:04 AM GMTU.S. Food and Drug Administration hss approved Sarclisa (isatuximab-irfc), in combination with pomalidomide and dexamethasone, for the treatment of...
